Brought to you by 
TriPath buys CAS from Becton
15 Dec 1999
Executive Summary
TriPath bought Becton Dickinson's Cell Analysis Systems division, mostly for its intellectual property. The acquisition adds 24 US patents (and their foreign counterparts), bringing TriPath's estate to 100 US issued and 30 pending.
Deal Industry
- Biotechnology
-
In Vitro Diagnostics
- Cytology
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TriPath buys CAS from Becton
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice